Novo's R&D restructuring adds to innovation push

Four new R&D centers fueled by a dedicated business development unit and increased investment in machine learning and AI form the basis of an R&D restructuring announced by Novo Nordisk A/S (CSE:NOVO B; NYSE:NVO) on Sept. 18.

The initiative is the latest step in a push begun by Novo in 2015 to find innovative

Read the full 532 word article

User Sign In